GlassScriptPhysician profile
Kyle M Ferguson
NPI 1437554102
$4,083.84
in general payments reported to CMS, 2019-2025
18 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,032 · 2020: $256 · 2021: $248 · 2022: $585 · 2023: $264 · 2024: $346 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,574.63 | 2019 | |
| Alcon Vision LLC | $1,258.44 | 2019-2025 | Argos, Clareon, Hydrus Microstent |
| Dompe US, INC. | $176.83 | 2024-2025 | Oxervate |
| Allergan, INC. | $160.83 | 2019-2021 | |
| Ivantis, INC | $153.64 | 2019 | |
| Oyster Point Pharma, INC. | $138.48 | 2022 | |
| Sun Pharmaceutical Industries INC. | $123.43 | 2019 | |
| Vantage Technology LLC | $117.47 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $111.27 | 2020 | |
| Abbvie INC. | $58.95 | 2022-2023 | |
| Rxsight INC | $55.20 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Spark Therapeutics, INC. | $34.12 | 2021-2022 | |
| Lkc Technologies, INC. | $25.16 | 2025 | |
| Mallinckrodt Hospital Products INC. | $22.48 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.59 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Aerie Pharmaceuticals, INC. | $16.96 | 2021 | |
| Bausch & Lomb Americas INC. | $14.96 | 2024 | Scoutpro Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.